IDIS PARTNER FOR LIFE Logo (USPTO, 10.02.2010)
USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke IDIS PARTNER FOR LIFE wurde als Wort-Bildmarke am 10.02.2010 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 13.09.2011 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".
| Markenform | Wort-Bildmarke |
| Aktenzeichen | 77932256 |
| Registernummer | 4026753 |
| Anmeldedatum | 10. Februar 2010 |
| Veröffentlichungsdatum | 12. Oktober 2010 |
| Eintragungsdatum | 13. September 2011 |
Markeninhaber
Idis House, Churchfield Road, Weybridge
Surrey KT13 8DB
GB
Surrey KT13 8DB
GB
Markenvertreter
Waren und Dienstleistungen
35
Business consultancy services; procurement, namely, purchasing of pharmaceutical products, medicines and drugs for others; business advisory, business management, business information and consultancy services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and distribution solutions; provision of business networking services; information, advisory and consultancy services, namely, business information and business advisory services in the fields of medical devices and pharmaceuticals and business consultancy services in the field of early access programs and clinical trials
42
Medical and scientific research, namely, managing clinical trials for others not for business purposes; preparation of expert scientific reports in the fields of pharmaceutical research and clinical trials
44
Medical consultancy and advisory services in connection with pharmaceutical preparations and substances, drugs and medicines
45
Regulatory affairs consultancy for the purpose of ensuring compliance with laws and regulations pertaining to pharmaceutical products, medicines and drugs, namely, reviewing and formulating standards and practices, identifying government regulations and policies impacting on pricing and reimbursement and developing strategies to manage them, advising others on regulatory requirements, liaising with, and making presentations to, regulatory authorities, not including providing mail order services featuring specialized information relating to drugs and drug therapy
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1377932256